Kaposi's sarcoma differential diagnosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 1: Line 1:
__NOTOC__
__NOTOC__


{{CMG}} {{AE}} {{F.K}} {{HL}} {{ADS}}
{{CMG}} {{AE}} {{F.K}} {{HL}} {{ADS}} {{Hudakarman}}
[[Image:Home_logo1.png|right|250px|link=https://www.wikidoc.org/index.php/Kaposi%27s_sarcoma]]
[[Image:Home_logo1.png|right|250px|link=https://www.wikidoc.org/index.php/Kaposi%27s_sarcoma]]


==Overview==
==Overview==
Kaposi's sarcoma must be differentiated from other diseases that cause similar [[cutaneous]], [[pulmonary]], and [[gastrointestinal]] involvement, such as [[bacillary angiomatosis]], [[AIDS]]-related [[lymphoma]], and [[seborrheic keratosis]].
Kaposi's sarcoma must be differentiated from other [[diseases]] that cause similar [[cutaneous]], [[pulmonary]], and [[gastrointestinal]] involvement, such as [[bacillary angiomatosis]], [[AIDS]]-related [[lymphoma]], and [[seborrheic keratosis]].
==Differentiating Kaposi's Sarcoma from other Diseases==
==Differentiating Kaposi's Sarcoma from other Diseases==
*Kaposi's sarcoma must be differentiated from other diseases that cause similar [[cutaneous]], [[pulmonary]], and [[gastrointestinal]] involvement.<ref name="radio">Kaposi's Sarcoma. Radiopaedia (2015) http://radiopaedia.org/articles/kaposi-sarcoma Accessed on January, 19 2016</ref><ref name="patho">Libre Pathology. Kaposi's sarcoma (2015) http://librepathology.org/wiki/index.php/File:Kaposi_sarcoma_low_intermed_mag.jpg Accessed on January, 19 2016</ref><ref name="patho2">Kaposi's Sarcoma. PathologyOutlines (2015) http://www.pathologyoutlines.com/topic/skintumornonmelanocytickaposisarcoma.html Accessed on January, 19 2015</ref>
*Kaposi's sarcoma must be differentiated from other [[diseases]] that cause similar [[cutaneous]], [[pulmonary]], and [[gastrointestinal]] involvement.<ref name="radio">Kaposi's Sarcoma. Radiopaedia (2015) http://radiopaedia.org/articles/kaposi-sarcoma Accessed on January, 19 2016</ref><ref name="patho">Libre Pathology. Kaposi's sarcoma (2015) http://librepathology.org/wiki/index.php/File:Kaposi_sarcoma_low_intermed_mag.jpg Accessed on January, 19 2016</ref><ref name="patho2">Kaposi's Sarcoma. PathologyOutlines (2015) http://www.pathologyoutlines.com/topic/skintumornonmelanocytickaposisarcoma.html Accessed on January, 19 2015</ref><small>
<small>
 
 
 
{|
{|
! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases
! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases
Line 40: Line 42:
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Bacillary angiomatosis]] <ref name="pmid7553576">{{cite journal |vauthors=Tappero JW, Perkins BA, Wenger JD, Berger TG |title=Cutaneous manifestations of opportunistic infections in patients infected with human immunodeficiency virus |journal=Clin. Microbiol. Rev. |volume=8 |issue=3 |pages=440–50 |date=July 1995 |pmid=7553576 |pmc=174635 |doi= |url=}}</ref>
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Bacillary angiomatosis]] <ref name="pmid7553576">{{cite journal |vauthors=Tappero JW, Perkins BA, Wenger JD, Berger TG |title=Cutaneous manifestations of opportunistic infections in patients infected with human immunodeficiency virus |journal=Clin. Microbiol. Rev. |volume=8 |issue=3 |pages=440–50 |date=July 1995 |pmid=7553576 |pmc=174635 |doi= |url=}}</ref>
| style="background:#F5F5F5;" align="left" |  
| style="background:#F5F5F5;" align="left" |  
* [[Human Immunodeficiency Virus (HIV)|HIV]]
*[[Human Immunodeficiency Virus (HIV)|HIV]]
* [[Chronic lymphocytic leukemia]]
*[[Chronic lymphocytic leukemia]]
* Cytotoxic [[chemotherapy]]
* Cytotoxic [[chemotherapy]]
* [[Organ transplant|Organ transplantation]]
*[[Organ transplant|Organ transplantation]]
| style="background:#F5F5F5;" align="center" | –
| style="background:#F5F5F5;" align="center" | –
| style="background:#F5F5F5;" align="center" | +
| style="background:#F5F5F5;" align="center" | +
| style="background:#F5F5F5;" align="center" | Any age, usually between 20 -50 years
| style="background:#F5F5F5;" align="center" | Any age, usually between 20 -50 years
| style="background:#F5F5F5;" align="center" | Solitary or multiple red, purple, flesh-colored, or colorless [[Papule|papules]]
| style="background:#F5F5F5;" align="center" | Solitary or multiple red, purple, flesh-colored, or colorless [[Papule|papules]]
Line 54: Line 56:
| style="background:#F5F5F5;" align="center" | –
| style="background:#F5F5F5;" align="center" | –
| style="background:#F5F5F5;" align="left" |
| style="background:#F5F5F5;" align="left" |
* [[Anorexia]]
*[[Anorexia]]
* [[Weight loss]]
*[[Weight loss]]
* [[Abdominal pain]]  
*[[Abdominal pain]]
* [[Nausea and vomiting]]
*[[Nausea and vomiting]]
* [[Headache]]
*[[Headache]]
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | Nl
Line 68: Line 70:
| style="background:#F5F5F5;" align="center" | Clinical manifestation
| style="background:#F5F5F5;" align="center" | Clinical manifestation
| style="background:#F5F5F5;" align="left" |  
| style="background:#F5F5F5;" align="left" |  
*[[Mental disorder|Psychiatric disorders]]  
*[[Mental disorder|Psychiatric disorders]]
*[[Personality|Personality changes]]
*[[Personality|Personality changes]]
*[[Seizure]]
*[[Seizure]]
Line 74: Line 76:
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Arteriovenous malformation]] <ref name="pmid23125071">{{cite journal |vauthors=Whitehead KJ, Smith MC, Li DY |title=Arteriovenous malformations and other vascular malformation syndromes |journal=Cold Spring Harb Perspect Med |volume=3 |issue=2 |pages=a006635 |date=February 2013 |pmid=23125071 |pmc=3552339 |doi=10.1101/cshperspect.a006635 |url=}}</ref>
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Arteriovenous malformation]] <ref name="pmid23125071">{{cite journal |vauthors=Whitehead KJ, Smith MC, Li DY |title=Arteriovenous malformations and other vascular malformation syndromes |journal=Cold Spring Harb Perspect Med |volume=3 |issue=2 |pages=a006635 |date=February 2013 |pmid=23125071 |pmc=3552339 |doi=10.1101/cshperspect.a006635 |url=}}</ref>
| style="background:#F5F5F5;" align="left" |
| style="background:#F5F5F5;" align="left" |
* [[Idiopathic]]
*[[Idiopathic]]
| style="background:#F5F5F5;" align="center" | +
| style="background:#F5F5F5;" align="center" | +
| style="background:#F5F5F5;" align="center" | –
| style="background:#F5F5F5;" align="center" | –
| style="background:#F5F5F5;" align="center" | Any age
| style="background:#F5F5F5;" align="center" | Any age
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | –
| style="background:#F5F5F5;" align="center" | –
| style="background:#F5F5F5;" align="center" | +
| style="background:#F5F5F5;" align="center" | +
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | –
| style="background:#F5F5F5;" align="center" | –
| style="background:#F5F5F5;" align="center" | –
| style="background:#F5F5F5;" align="center" | –
| style="background:#F5F5F5;" align="left" |
| style="background:#F5F5F5;" align="left" |
* [[Headache]]
*[[Headache]]
* [[Neurologic diseases|Neurologic deficits]]
*[[Neurologic diseases|Neurologic deficits]]
* [[Congestive heart failure|Heart failure]]
*[[Congestive heart failure|Heart failure]]
* [[Macrocephaly]]
*[[Macrocephaly]]
| style="background:#F5F5F5;" align="center" |Nl
| style="background:#F5F5F5;" align="center" |Nl
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | Nl
Line 95: Line 97:
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" |NA
| style="background:#F5F5F5;" align="center" |NA
| style="background:#F5F5F5;" align="center" | [[Imaging]]
| style="background:#F5F5F5;" align="center" |[[Imaging]]
| style="background:#F5F5F5;" align="left" |
| style="background:#F5F5F5;" align="left" |
* [[Hereditary hemorrhagic telangiectasia]]
*[[Hereditary hemorrhagic telangiectasia]]
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Acroangiodermatitis]]<ref name="pmid17868541">{{cite journal |vauthors=Lugović L, Pusić J, Situm M, Buljan M, Bulat V, Sebetić K, Soldo-Belić A |title=Acroangiodermatitis (pseudo-Kaposi sarcoma): three case reports |journal=Acta Dermatovenerol Croat |volume=15 |issue=3 |pages=152–7 |date=2007 |pmid=17868541 |doi= |url=}}</ref>
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Acroangiodermatitis]]<ref name="pmid17868541">{{cite journal |vauthors=Lugović L, Pusić J, Situm M, Buljan M, Bulat V, Sebetić K, Soldo-Belić A |title=Acroangiodermatitis (pseudo-Kaposi sarcoma): three case reports |journal=Acta Dermatovenerol Croat |volume=15 |issue=3 |pages=152–7 |date=2007 |pmid=17868541 |doi= |url=}}</ref>
| style="background:#F5F5F5;" align="left" |
| style="background:#F5F5F5;" align="left" |
* [[Idiopathic]]
*[[Idiopathic]]
* Hyperplasia of pre-existing vasculature
* Hyperplasia of pre-existing vasculature
* [[Hypertension|HTN]]
*[[Hypertension|HTN]]
| style="background:#F5F5F5;" align="center" | –
| style="background:#F5F5F5;" align="center" | –
| style="background:#F5F5F5;" align="center" | –
| style="background:#F5F5F5;" align="center" | –
Line 121: Line 123:
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="left" |
| style="background:#F5F5F5;" align="left" |
* [[Hyperkeratosis]]
*[[Hyperkeratosis]]
* Parakeratosis
* Parakeratosis
* [[Acanthosis nigricans|Acanthosis]]
*[[Acanthosis nigricans|Acanthosis]]
* Mild spongiosis
* Mild spongiosis
| style="background:#F5F5F5;" align="center" | Clinical manifesttations
| style="background:#F5F5F5;" align="center" | Clinical manifesttations
| style="background:#F5F5F5;" align="left" |
| style="background:#F5F5F5;" align="left" |
* [[Amputation]]  
*[[Amputation]]
* [[Hemodialysis|Haemodialysis]] patients with [[Arteriovenous fistula|arteriovenous shunts]]
*[[Hemodialysis|Haemodialysis]] patients with [[Arteriovenous fistula|arteriovenous shunts]]
* [[Hepatitis C]]
*[[Hepatitis C]]
* [[Venous insufficiency|Chronic venous insufficiency]]  
*[[Venous insufficiency|Chronic venous insufficiency]]
* [[Arteriovenous malformation|AV malformations]]
*[[Arteriovenous malformation|AV malformations]]
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" | [[Angiosarcoma]] <ref name="pmid2734404">{{cite journal |vauthors=Barttelbort SW, Stahl R, Ariyan S |title=Cutaneous angiosarcoma of the face and scalp |journal=Plast. Reconstr. Surg. |volume=84 |issue=1 |pages=55–9 |date=July 1989 |pmid=2734404 |doi= |url=}}</ref>
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Angiosarcoma]] <ref name="pmid2734404">{{cite journal |vauthors=Barttelbort SW, Stahl R, Ariyan S |title=Cutaneous angiosarcoma of the face and scalp |journal=Plast. Reconstr. Surg. |volume=84 |issue=1 |pages=55–9 |date=July 1989 |pmid=2734404 |doi= |url=}}</ref>
| style="background:#F5F5F5;" align="left" |
| style="background:#F5F5F5;" align="left" |
* [[Idiopathic]]
*[[Idiopathic]]
| style="background:#F5F5F5;" align="center" | –
| style="background:#F5F5F5;" align="center" | –
| style="background:#F5F5F5;" align="center" | –
| style="background:#F5F5F5;" align="center" | –
Line 154: Line 156:
* Intercellular and intracellular lumina with or without [[Red blood cell|red cells]]
* Intercellular and intracellular lumina with or without [[Red blood cell|red cells]]
* Intermediate filaments and pinocytotic vesicles in [[cytoplasm]]
* Intermediate filaments and pinocytotic vesicles in [[cytoplasm]]
* [[Weibel-Palade body|Weibel-Palade bodies]]
*[[Weibel-Palade body|Weibel-Palade bodies]]
| style="background:#F5F5F5;" align="center" | [[Biopsy]]
| style="background:#F5F5F5;" align="center" |[[Biopsy]]
| style="background:#F5F5F5;" align="center" |NA
| style="background:#F5F5F5;" align="center" |NA
|-
|-
Line 181: Line 183:
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Masson's [[hemangioma]] <ref name="pmid22993679">{{cite journal |vauthors=Park KK, Won YS, Yang JY, Choi CS, Han KY |title=Intravascular Papillary Endothelial Hyperplasia (Masson tumor) of the Skull : Case Report and Literature Review |journal=J Korean Neurosurg Soc |volume=52 |issue=1 |pages=52–4 |date=July 2012 |pmid=22993679 |pmc=3440504 |doi=10.3340/jkns.2012.52.1.52 |url=}}</ref>
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Masson's [[hemangioma]] <ref name="pmid22993679">{{cite journal |vauthors=Park KK, Won YS, Yang JY, Choi CS, Han KY |title=Intravascular Papillary Endothelial Hyperplasia (Masson tumor) of the Skull : Case Report and Literature Review |journal=J Korean Neurosurg Soc |volume=52 |issue=1 |pages=52–4 |date=July 2012 |pmid=22993679 |pmc=3440504 |doi=10.3340/jkns.2012.52.1.52 |url=}}</ref>
| style="background:#F5F5F5;" align="left" |
| style="background:#F5F5F5;" align="left" |
* [[Idiopathic]]
*[[Idiopathic]]
| style="background:#F5F5F5;" align="center" | –
| style="background:#F5F5F5;" align="center" | –
| style="background:#F5F5F5;" align="center" | –
| style="background:#F5F5F5;" align="center" | –
Line 200: Line 202:
| style="background:#F5F5F5;" align="left" |
| style="background:#F5F5F5;" align="left" |
* Papillary fronds lined by proliferating [[endothelium]]
* Papillary fronds lined by proliferating [[endothelium]]
| style="background:#F5F5F5;" align="center" | [[Biopsy]]
| style="background:#F5F5F5;" align="center" |[[Biopsy]]
| style="background:#F5F5F5;" align="left" |
| style="background:#F5F5F5;" align="left" |
* [[Hemangioma]]
*[[Hemangioma]]
* [[Pyogenic granuloma|Pyogenic granulomas]]
*[[Pyogenic granuloma|Pyogenic granulomas]]
* [[Lymphangioma overview|Lymphangiomas]]
*[[Lymphangioma overview|Lymphangiomas]]
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Seborrheic keratosis]] <ref name="pmid18845088">{{cite journal |vauthors=Noiles K, Vender R |title=Are all seborrheic keratoses benign? Review of the typical lesion and its variants |journal=J Cutan Med Surg |volume=12 |issue=5 |pages=203–10 |date=2008 |pmid=18845088 |doi=10.2310/7750.2008.07096 |url=}}</ref>
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Seborrheic keratosis]] <ref name="pmid18845088">{{cite journal |vauthors=Noiles K, Vender R |title=Are all seborrheic keratoses benign? Review of the typical lesion and its variants |journal=J Cutan Med Surg |volume=12 |issue=5 |pages=203–10 |date=2008 |pmid=18845088 |doi=10.2310/7750.2008.07096 |url=}}</ref>
| style="background:#F5F5F5;" align="left" |
| style="background:#F5F5F5;" align="left" |
* Clonal expansion of a mutated epidermal [[keratinocyte]]
* Clonal expansion of a mutated epidermal [[keratinocyte]]
| style="background:#F5F5F5;" align="center" | +
| style="background:#F5F5F5;" align="center" | +
| style="background:#F5F5F5;" align="center" | –
| style="background:#F5F5F5;" align="center" | –
| style="background:#F5F5F5;" align="center" | Any age
| style="background:#F5F5F5;" align="center" | Any age
Line 230: Line 232:
| style="background:#F5F5F5;" align="center" | Clinical manifestations
| style="background:#F5F5F5;" align="center" | Clinical manifestations
| style="background:#F5F5F5;" align="left" |
| style="background:#F5F5F5;" align="left" |
* [[Dermatosis papulosa nigra]]
*[[Dermatosis papulosa nigra]]
* Stucco keratosis
* Stucco keratosis
* Melanoacanthoma
* Melanoacanthoma
Line 237: Line 239:
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Systemic lupus erythematosus]] ([[SLE]]) <ref name="pmid22888407">{{cite journal |vauthors=Uva L, Miguel D, Pinheiro C, Freitas JP, Marques Gomes M, Filipe P |title=Cutaneous manifestations of systemic lupus erythematosus |journal=Autoimmune Dis |volume=2012 |issue= |pages=834291 |date=2012 |pmid=22888407 |pmc=3410306 |doi=10.1155/2012/834291 |url=}}</ref>
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Systemic lupus erythematosus]] ([[SLE]]) <ref name="pmid22888407">{{cite journal |vauthors=Uva L, Miguel D, Pinheiro C, Freitas JP, Marques Gomes M, Filipe P |title=Cutaneous manifestations of systemic lupus erythematosus |journal=Autoimmune Dis |volume=2012 |issue= |pages=834291 |date=2012 |pmid=22888407 |pmc=3410306 |doi=10.1155/2012/834291 |url=}}</ref>
| style="background:#F5F5F5;" align="left" |
| style="background:#F5F5F5;" align="left" |
* [[Idiopathic]]
*[[Idiopathic]]
| style="background:#F5F5F5;" align="center" | –
| style="background:#F5F5F5;" align="center" | –
| style="background:#F5F5F5;" align="center" | –
| style="background:#F5F5F5;" align="center" | –
| style="background:#F5F5F5;" align="center" | More common in female, typically in the 20 to 30 years
| style="background:#F5F5F5;" align="center" | More common in female, typically in the 20 to 30 years
| style="background:#F5F5F5;" align="left" |
| style="background:#F5F5F5;" align="left" |
* [[Erythema]] on the [[Mouth|nasolabial folds]]
*[[Erythema]] on the [[Mouth|nasolabial folds]]
* [[Macule|Macular]] or diffusely erythematous in sun-exposed areas
*[[Macule|Macular]] or diffusely erythematous in sun-exposed areas
* Discoid rash
* Discoid rash
| style="background:#F5F5F5;" align="center" | ±
| style="background:#F5F5F5;" align="center" | ±
Line 251: Line 253:
| style="background:#F5F5F5;" align="center" | ±
| style="background:#F5F5F5;" align="center" | ±
| style="background:#F5F5F5;" align="left" |
| style="background:#F5F5F5;" align="left" |
* [[Weight loss]]
*[[Weight loss]]
* [[Headache]]
*[[Headache]]
* [[Arthralgia]]
*[[Arthralgia]]
* [[Myalgia]]
*[[Myalgia]]
* [[Nausea and vomiting|Nausea]]
*[[Nausea and vomiting|Nausea]]
* [[Dyspepsia]]
*[[Dyspepsia]]
* [[Pleuritic chest pain]]
*[[Pleuritic chest pain]]
* [[Dyspnea]]
*[[Dyspnea]]
* [[Hematuria]]
*[[Hematuria]]
| style="background:#F5F5F5;" align="center" | ↑
| style="background:#F5F5F5;" align="center" | ↑
| style="background:#F5F5F5;" align="center" | ↓
| style="background:#F5F5F5;" align="center" | ↓
Line 266: Line 268:
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="left" |
| style="background:#F5F5F5;" align="left" |
* [[Hyperkeratosis]], epidermal [[atrophy]], vacuolar interface [[dermatitis]]
*[[Hyperkeratosis]], epidermal [[atrophy]], vacuolar interface [[dermatitis]]
* Thickening of the [[basement membrane]]
* Thickening of the [[basement membrane]]
* Superficial, [[Perivascular cell|perivascular]], and perifollicular [[Monocyte|mononuclear cell]] inflammatory infiltrate
* Superficial, [[Perivascular cell|perivascular]], and perifollicular [[Monocyte|mononuclear cell]] inflammatory infiltrate
| style="background:#F5F5F5;" align="center" | Clinical manifestations
| style="background:#F5F5F5;" align="center" | Clinical manifestations
| style="background:#F5F5F5;" align="left" |
| style="background:#F5F5F5;" align="left" |
* [[Raynaud's phenomenon|Raynaud phenomenon]]
*[[Raynaud's phenomenon|Raynaud phenomenon]]
* [[Neuropsychiatry|Neuropsychiatric]] symptoms
*[[Neuropsychiatry|Neuropsychiatric]] symptoms
* [[Pleural effusion]]
*[[Pleural effusion]]
* [[Peptic ulcer|Peptic ulcer disease]]
*[[Peptic ulcer|Peptic ulcer disease]]
* [[Pericarditis]]
*[[Pericarditis]]
* [[Myocarditis]]
*[[Myocarditis]]
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Pyogenic]] granuloma <ref name="pmid22434943">{{cite journal |vauthors=Kamal R, Dahiya P, Puri A |title=Oral pyogenic granuloma: Various concepts of etiopathogenesis |journal=J Oral Maxillofac Pathol |volume=16 |issue=1 |pages=79–82 |date=January 2012 |pmid=22434943 |pmc=3303528 |doi=10.4103/0973-029X.92978 |url=}}</ref>
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Pyogenic]] granuloma <ref name="pmid22434943">{{cite journal |vauthors=Kamal R, Dahiya P, Puri A |title=Oral pyogenic granuloma: Various concepts of etiopathogenesis |journal=J Oral Maxillofac Pathol |volume=16 |issue=1 |pages=79–82 |date=January 2012 |pmid=22434943 |pmc=3303528 |doi=10.4103/0973-029X.92978 |url=}}</ref>
| style="background:#F5F5F5;" align="left" |
| style="background:#F5F5F5;" align="left" |
* [[Physical trauma|Trauma]]
*[[Physical trauma|Trauma]]
* Hormonal influences  
* Hormonal influences
* [[Virus|Viruses]]
*[[Virus|Viruses]]
* Cytogenetic clonal deletion abnormalities
* Cytogenetic clonal deletion abnormalities
| style="background:#F5F5F5;" align="center" | +
| style="background:#F5F5F5;" align="center" | +
| style="background:#F5F5F5;" align="center" | +
| style="background:#F5F5F5;" align="center" | +
| style="background:#F5F5F5;" align="center" | Any age, usually in 20-30 years
| style="background:#F5F5F5;" align="center" | Any age, usually in 20-30 years
| style="background:#F5F5F5;" align="left" |
| style="background:#F5F5F5;" align="left" |
Line 291: Line 293:
* Lobular [[capillary hemangioma]]
* Lobular [[capillary hemangioma]]
| style="background:#F5F5F5;" align="center" | –
| style="background:#F5F5F5;" align="center" | –
| style="background:#F5F5F5;" align="center" | +
| style="background:#F5F5F5;" align="center" | +
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | –
| style="background:#F5F5F5;" align="center" | –
Line 303: Line 305:
| style="background:#F5F5F5;" align="left" |
| style="background:#F5F5F5;" align="left" |
* Neutrophilic infiltration
* Neutrophilic infiltration
* [[Bleeding|Hemorrhage]]
*[[Bleeding|Hemorrhage]]
* [[Necrosis]] of the overlying [[Epidermis (skin)|epidermis]]
*[[Necrosis]] of the overlying [[Epidermis (skin)|epidermis]]
| style="background:#F5F5F5;" align="center" | Clinical manifestation
| style="background:#F5F5F5;" align="center" | Clinical manifestation
| style="background:#F5F5F5;" align="center" |NA
| style="background:#F5F5F5;" align="center" |NA
Line 310: Line 312:
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Benign lymphangioendothelioma <ref name="pmid10935645">{{cite journal |vauthors=Guillou L, Fletcher CD |title=Benign lymphangioendothelioma (acquired progressive lymphangioma): a lesion not to be confused with well-differentiated angiosarcoma and patch stage Kaposi's sarcoma: clinicopathologic analysis of a series |journal=Am. J. Surg. Pathol. |volume=24 |issue=8 |pages=1047–57 |date=August 2000 |pmid=10935645 |doi= |url=}}</ref>
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Benign lymphangioendothelioma <ref name="pmid10935645">{{cite journal |vauthors=Guillou L, Fletcher CD |title=Benign lymphangioendothelioma (acquired progressive lymphangioma): a lesion not to be confused with well-differentiated angiosarcoma and patch stage Kaposi's sarcoma: clinicopathologic analysis of a series |journal=Am. J. Surg. Pathol. |volume=24 |issue=8 |pages=1047–57 |date=August 2000 |pmid=10935645 |doi= |url=}}</ref>
| style="background:#F5F5F5;" align="left" |
| style="background:#F5F5F5;" align="left" |
* [[Idiopathic]]
*[[Idiopathic]]
| style="background:#F5F5F5;" align="center" | –
| style="background:#F5F5F5;" align="center" | –
| style="background:#F5F5F5;" align="center" | +
| style="background:#F5F5F5;" align="center" | +
| style="background:#F5F5F5;" align="center" | Any ages, median age is 50 years  
| style="background:#F5F5F5;" align="center" | Any ages, median age is 50 years
| style="background:#F5F5F5;" align="left" |
| style="background:#F5F5F5;" align="left" |
* single, slowly expanding patch, [[plaque]], or [[Nodule (medicine)|nodule]]
* single, slowly expanding patch, [[plaque]], or [[Nodule (medicine)|nodule]]
Line 334: Line 336:
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Cavernous [[hemangioma]] <ref name="pmid229814">{{cite journal |vauthors=Goldberg RE, Pheasant TR, Shields JA |title=Cavernous hemangioma of the retina. A four-generation pedigree with neurocutaneous manifestations and an example of bilateral retinal involvement |journal=Arch. Ophthalmol. |volume=97 |issue=12 |pages=2321–4 |date=December 1979 |pmid=229814 |doi= |url=}}</ref>
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Cavernous [[hemangioma]] <ref name="pmid229814">{{cite journal |vauthors=Goldberg RE, Pheasant TR, Shields JA |title=Cavernous hemangioma of the retina. A four-generation pedigree with neurocutaneous manifestations and an example of bilateral retinal involvement |journal=Arch. Ophthalmol. |volume=97 |issue=12 |pages=2321–4 |date=December 1979 |pmid=229814 |doi= |url=}}</ref>
| style="background:#F5F5F5;" align="left" |
| style="background:#F5F5F5;" align="left" |
* [[Idiopathic]]
*[[Idiopathic]]
| style="background:#F5F5F5;" align="center" | –
| style="background:#F5F5F5;" align="center" | –
| style="background:#F5F5F5;" align="center" | –
| style="background:#F5F5F5;" align="center" | –
Line 355: Line 357:
| style="background:#F5F5F5;" align="center" | Clinical manidestation
| style="background:#F5F5F5;" align="center" | Clinical manidestation
| style="background:#F5F5F5;" align="left" |
| style="background:#F5F5F5;" align="left" |
* [[Diplopia]]
*[[Diplopia]]
* Decreased [[color vision]]
* Decreased [[color vision]]
* [[Visual field loss|Visual field deficits]]
*[[Visual field loss|Visual field deficits]]
|-
|-
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases

Revision as of 15:12, 10 October 2019


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Farima Kahe M.D. [2] Haytham Allaham, M.D. [3] Amandeep Singh M.D.[4] Huda A. Karman, M.D.

Overview

Kaposi's sarcoma must be differentiated from other diseases that cause similar cutaneous, pulmonary, and gastrointestinal involvement, such as bacillary angiomatosis, AIDS-related lymphoma, and seborrheic keratosis.

Differentiating Kaposi's Sarcoma from other Diseases


Diseases Etiology Congenital Acquired Demography Clinical manifestations Lab findings Gold standard diagnosis Associated findings
Symptoms Signs CBC LFT ESR/CRP Histopathology
Appearance Fever Bleeding BP Hepatosplenomegaly Lymphadenopathy Other WBC Hb Plt
Bacillary angiomatosis [4] + Any age, usually between 20 -50 years Solitary or multiple red, purple, flesh-colored, or colorless papules ± ± Nl Nl Nl Nl Nl Nl Clinical manifestation
Arteriovenous malformation [5] + Any age Nl + Nl Nl Nl Nl Nl Nl NA Imaging
Acroangiodermatitis[6] Any age, more in males Purplish-blue to brown papules and plaques Nl
  • Paralysed legs
Nl Nl Nl Nl Nl Clinical manifesttations
Angiosarcoma [7] Adults, more in males Enlarging bruise, a blue-black nodule, or an unhealed ulceration Nl Nl Nl Nl Biopsy NA
Diseases Etiology Congenital Acquired Demography Appearance Fever Bleeding BP Hepatosplenomegaly Lymphadenopathy Other WBC Hb Plt LFT ESR/CRP Histopathology Gold standard diagnosis Associated findings
Masson's hemangioma [8] Rare
  • Normal
Nl Nl Nl Nl Nl Nl Biopsy
Seborrheic keratosis [9] + Any age Nl Nl Nl Nl Nl Nl
  • Papillomatous epithelial proliferation containing horn cysts
Clinical manifestations
Systemic lupus erythematosus (SLE) [10] More common in female, typically in the 20 to 30 years ± ± ± Nl Nl Clinical manifestations
Pyogenic granuloma [11]
  • Trauma
  • Hormonal influences
  • Viruses
  • Cytogenetic clonal deletion abnormalities
+ + Any age, usually in 20-30 years + Nl Nl Nl Nl Nl Nl Clinical manifestation NA
Benign lymphangioendothelioma [12] + Any ages, median age is 50 years Nl Nl Nl Nl Nl Nl
  • Thin-walled endothelial-lined spaces that are interspersed between strands of collagen
Biopsy NA
Cavernous hemangioma [13] Usually in third to fifth decades of life.
  • Painless, slowly progressive protrusion or bulging of their globe
Nl Nl Nl Nl Nl Nl
  • Engorged vascular channels, which are tightly knit and separated by fibrous septae
Clinical manidestation
Diseases Etiology Congenital Acquired Demography Appearance Fever Bleeding BP Hepatosplenomegaly Lymphadenopathy Other WBC Hb Plt LFT ESR/CRP Histopathology Gold standard diagnosis Associated findings

References

  1. Kaposi's Sarcoma. Radiopaedia (2015) http://radiopaedia.org/articles/kaposi-sarcoma Accessed on January, 19 2016
  2. Libre Pathology. Kaposi's sarcoma (2015) http://librepathology.org/wiki/index.php/File:Kaposi_sarcoma_low_intermed_mag.jpg Accessed on January, 19 2016
  3. Kaposi's Sarcoma. PathologyOutlines (2015) http://www.pathologyoutlines.com/topic/skintumornonmelanocytickaposisarcoma.html Accessed on January, 19 2015
  4. Tappero JW, Perkins BA, Wenger JD, Berger TG (July 1995). "Cutaneous manifestations of opportunistic infections in patients infected with human immunodeficiency virus". Clin. Microbiol. Rev. 8 (3): 440–50. PMC 174635. PMID 7553576.
  5. Whitehead KJ, Smith MC, Li DY (February 2013). "Arteriovenous malformations and other vascular malformation syndromes". Cold Spring Harb Perspect Med. 3 (2): a006635. doi:10.1101/cshperspect.a006635. PMC 3552339. PMID 23125071.
  6. Lugović L, Pusić J, Situm M, Buljan M, Bulat V, Sebetić K, Soldo-Belić A (2007). "Acroangiodermatitis (pseudo-Kaposi sarcoma): three case reports". Acta Dermatovenerol Croat. 15 (3): 152–7. PMID 17868541.
  7. Barttelbort SW, Stahl R, Ariyan S (July 1989). "Cutaneous angiosarcoma of the face and scalp". Plast. Reconstr. Surg. 84 (1): 55–9. PMID 2734404.
  8. Park KK, Won YS, Yang JY, Choi CS, Han KY (July 2012). "Intravascular Papillary Endothelial Hyperplasia (Masson tumor) of the Skull : Case Report and Literature Review". J Korean Neurosurg Soc. 52 (1): 52–4. doi:10.3340/jkns.2012.52.1.52. PMC 3440504. PMID 22993679.
  9. Noiles K, Vender R (2008). "Are all seborrheic keratoses benign? Review of the typical lesion and its variants". J Cutan Med Surg. 12 (5): 203–10. doi:10.2310/7750.2008.07096. PMID 18845088.
  10. Uva L, Miguel D, Pinheiro C, Freitas JP, Marques Gomes M, Filipe P (2012). "Cutaneous manifestations of systemic lupus erythematosus". Autoimmune Dis. 2012: 834291. doi:10.1155/2012/834291. PMC 3410306. PMID 22888407.
  11. Kamal R, Dahiya P, Puri A (January 2012). "Oral pyogenic granuloma: Various concepts of etiopathogenesis". J Oral Maxillofac Pathol. 16 (1): 79–82. doi:10.4103/0973-029X.92978. PMC 3303528. PMID 22434943.
  12. Guillou L, Fletcher CD (August 2000). "Benign lymphangioendothelioma (acquired progressive lymphangioma): a lesion not to be confused with well-differentiated angiosarcoma and patch stage Kaposi's sarcoma: clinicopathologic analysis of a series". Am. J. Surg. Pathol. 24 (8): 1047–57. PMID 10935645.
  13. Goldberg RE, Pheasant TR, Shields JA (December 1979). "Cavernous hemangioma of the retina. A four-generation pedigree with neurocutaneous manifestations and an example of bilateral retinal involvement". Arch. Ophthalmol. 97 (12): 2321–4. PMID 229814.

Template:WH Template:WS